Theratechnologies
Theratechnologies was founded in 1993. Theratechnologies scientists discovered EGRIFTA® (tesamorelin for injection) in 1995. For the next 15 years, Theratechnologies continued to develop this innovative treatment for lipodystrophy in people living with HIV. In 2010, Theratechnologies received a marketing authorization for EGRIFTA® from the US Food and Drug Administration.
